HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katharina T Troppan Selected Research

Lymphoma (Lymphomas)

12/2015The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katharina T Troppan Research Topics

Disease

1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2016
1Neoplasm Metastasis (Metastasis)
04/2016
1Neoplasms (Cancer)
04/2016
1Lymphoma (Lymphomas)
12/2015
1Anemia
12/2015
1Human Influenza (Influenza)
10/2010

Drug/Important Bio-Agent (IBA)

1Fibrinogen (Factor I)FDA Link
04/2016
1Hemoglobins (Hemoglobin)IBA
12/2015
1Rituximab (Mabthera)FDA Link
12/2015
1RNA (Ribonucleic Acid)IBA
10/2010
1Viral RNAIBA
10/2010